scholarly journals Experienced Homophobia and HIV Infection Risk Among U.S. Gay, Bisexual, and Other Men Who Have Sex with Men: A Meta-Analysis

LGBT Health ◽  
2020 ◽  
Author(s):  
William L. Jeffries ◽  
Stephen A. Flores ◽  
Cherie R. Rooks-Peck ◽  
Deborah J. Gelaude ◽  
Lisa Belcher ◽  
...  
2019 ◽  
Vol 6 (10) ◽  
Author(s):  
Brendan L Harney ◽  
Paul A Agius ◽  
Carol El-Hayek ◽  
Christopher K Fairley ◽  
Eric P F Chow ◽  
...  

Abstract Background HIV and bacterial sexually transmissible infection (STI) notifications among men who have sex with men (MSM) have increased in Australia and many other countries. The relationship between HIV infection and other STIs has been demonstrated previously. However, the relationship between the cumulative history of STIs and subsequent HIV infection remains largely unexplored and limits our understanding of the mechanisms underpinning the elevated HIV risk. Methods Data from HIV-negative MSM who attended high–HIV caseload primary care clinics in Melbourne, Australia, from 2007 to 2014 with 2 or more HIV and STI tests were included. Controlling for sexual behaviors self-reported at clinic visits, discrete time survival analyses using generalized linear modeling estimated the effect of an STI at the prior test event and the cumulative history of STIs (none, 1, 2, or more [repeated]) on risk of HIV infection. Results A total of 8941 MSM met the study criteria; 227 (2.5%) were diagnosed with HIV over the follow-up period. Adjusting for sexual behaviors, a cumulative history of repeated rectal gonorrhea infections (adjusted hazard ratio [aHR], 6.27; 95% confidence interval [CI], 2.68–14.50) and a single rectal gonorrhea infection (aHR, 2.09; 95% CI, 1.15–3.79) were associated with increased HIV infection risk. Conclusions Repeated and single rectal gonorrhea infections were independently associated with increased HIV infection risk. These findings suggest that MSM with any history of rectal gonorrhea, particularly repeat rectal gonorrhea, represent a group for whom preventive interventions for HIV should be emphasized.


Author(s):  
Duncan A MacKellar ◽  
Linda A Valleroy ◽  
Gina M Secura ◽  
Stephanie Behel ◽  
Trista Bingham ◽  
...  

2015 ◽  
Vol 61 (3) ◽  
pp. 468-475 ◽  
Author(s):  
Martin Hoenigl ◽  
Nadir Weibel ◽  
Sanjay R. Mehta ◽  
Christy M. Anderson ◽  
Jeffrey Jenks ◽  
...  

2017 ◽  
Vol 94 (3) ◽  
pp. 163-168 ◽  
Author(s):  
Ke Yun ◽  
Jun-jie Xu ◽  
Jing Zhang ◽  
Jia-ming Li ◽  
Qing-hai Hu ◽  
...  

ObjectiveTo estimate the medicine-taking compliance (MTC) level, explore its facilitators and barriers, and quantify the association between MTC level and pre-exposure prophylaxis (PrEP) protective efficacy in individuals at risk of acquiring HIV being administered oral PrEP.DesignMeta-analysis.Data sourcesWe searched PubMed, Cochrane and Embase databases for published randomized controlled trials (RCTs) pertaining to MTC of oral PrEP for HIV prevention up to 16 January 2017.Review methodsThe pooled proportion of MTC and risk ratio (RR) of HIV incidences between intervention group and control group were estimated.ResultsWe identified 10 eligible studies with 24 193 participants. The overall pooled MTC for oral HIV PrEP was 59.9% (95% CI 43.1% to 74.6%). Subgroup analyses revealed that the MTC level of participants aged <30 years was lower than those equal or older than 30 years (34.9% vs 69.6%, p<0.001); those studies that enrolled only women as participants had lower MTC than those only recruiting either only men or both men and women (31.3% vs 71.7% and 31.3% vs 71.0%, all p<0.01). Additionally, the HIV infection risk increased as the MTC level declines, with the incidence RRs being 0.28 (95% CI 0.19 to 0.41), 0.42 (95% CI 0.29 to 0.62) and 0.75 (95% CI 0.45 to 1.25) in the good (≥80%), moderate (60%~80%) and poor (<60%) MTC subgroups, respectively (linear trend test p<0.01).ConclusionAccording to the pooled proportion, the MTC of oral HIV PrEP is almost moderate, and its proportion in women and younger participants was relatively low. The protective efficacy of oral PrEP for HIV prevention increased with MTC level. These findings indicated that it is necessary to identify measures to enhance MTC of oral PrEP in future clinical usage, especially in women and younger participants with high HIV infection risk.


2015 ◽  
Vol 12 (1) ◽  
pp. 116-129 ◽  
Author(s):  
William L. Jeffries ◽  
Deborah J. Gelaude ◽  
Elizabeth A. Torrone ◽  
Mari Gasiorowicz ◽  
Alexandra M. Oster ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document